- Home
- CDTG vs TURN Comparison
CDTG vs TURN Comparison
Compare CDTG & TURN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDTG
- TURN
- Stock Information
- Founded
- CDTG 2012
- TURN 1981
- Country
- CDTG China
- TURN United States
- Employees
- CDTG N/A
- TURN N/A
- Industry
- CDTG
- TURN Finance/Investors Services
- Sector
- CDTG
- TURN Finance
- Exchange
- CDTG NYSE
- TURN Nasdaq
- Market Cap
- CDTG 36.4M
- TURN 33.4M
- IPO Year
- CDTG 2024
- TURN N/A
- Fundamental
- Price
- CDTG $2.99
- TURN $3.23
- Analyst Decision
- CDTG
- TURN
- Analyst Count
- CDTG 0
- TURN 0
- Target Price
- CDTG N/A
- TURN N/A
- AVG Volume (30 Days)
- CDTG 27.8K
- TURN 8.3K
- Earning Date
- CDTG 11-15-2024
- TURN 11-11-2024
- Dividend Yield
- CDTG N/A
- TURN N/A
- EPS Growth
- CDTG 28.29
- TURN N/A
- EPS
- CDTG 0.81
- TURN N/A
- Revenue
- CDTG $34,209,919.00
- TURN $129,297.00
- Revenue This Year
- CDTG N/A
- TURN N/A
- Revenue Next Year
- CDTG N/A
- TURN N/A
- P/E Ratio
- CDTG $3.94
- TURN N/A
- Revenue Growth
- CDTG 18.58
- TURN 6.32
- 52 Week Low
- CDTG $2.50
- TURN $3.16
- 52 Week High
- CDTG $4.60
- TURN $4.47
- Technical
- Relative Strength Index (RSI)
- CDTG N/A
- TURN 29.51
- Support Level
- CDTG N/A
- TURN $3.16
- Resistance Level
- CDTG N/A
- TURN $3.28
- Average True Range (ATR)
- CDTG 0.00
- TURN 0.05
- MACD
- CDTG 0.00
- TURN -0.01
- Stochastic Oscillator
- CDTG 0.00
- TURN 30.43
About CDTG CDT ENVIRONMENTAL TECH INV HLDG LTD
CDT Environmental Technology Investment Holdings Ltd is a waste treatment company. The company generates revenue through the design, development, manufacture, sales, installation, operation and maintenance of sewage treatment systems and by providing sewage treatment services. It engages in two business lines namely, rural sewage treatment and septic tank treatment in both urban and rural areas.
About TURN 180 Degree Capital Corp.
180 Degree Capital Corp is active in the financial services domain. It is a non-diversified closed-end management investment company whose objective is to achieve long-term capital appreciation by making venture capital investments. It focuses its investments on companies commercializing and integrating products enabled by disruptive technologies mainly in the life sciences, precision medicine, and health industries.